Delivery Order SPE2DE24D0013-SPE2D625F35SP

Award Date 1/21/25
Potential Completion Date 1/28/25
Potential Value $204K
Federal Agency
Medical Supply Chain
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The award, valued at $16,320.00, is a firm fixed-price delivery order contract with no set-aside designation. The contract is for the provision of Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, and respiratory...
This federal contract award, valued at $14,448.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) and has no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA) to provide molecular diagnostic testing solutions, including GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and others. The contract, worth a ceiling value of $6,800.00, is a firm fixed-price delivery order...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The contract, valued at $5,440.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract is for the delivery of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), Methicillin-resistant Staphylococcus aureus (MRSA), and sexually transmitted diseases. The contract has a ceiling value of...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions specializing in advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and clinical testing. The contract, valued at $102,000.00, is a firm fixed-price delivery order awarded by the Defense Logistics Agency's Medical Supply Chain division. The contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated...
This federal contract award, valued at $10,200.00, was issued to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract does not have a set-aside designation....
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award, valued at $1,054.20, is a firm fixed-price delivery order contract with no set-aside designation. The contract requires Cepheid to provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions are used to detect a...
This federal contract award, valued at $3,994.64, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) and has a firm fixed price pricing type. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and...
This federal contract award, valued at $34,560.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order with a firm fixed-price pricing type, and no set-aside designation. Cepheid will provide its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of various infectious diseases, including COVID-19, influenza, and...
  • SPE2DE24D0013
    Indefinite Delivery Contract
  • SPE2DE24D0013-SPE2D625F35SP
    Delivery Order

This federal contract award, worth up to $204,000.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a firm fixed-price delivery order, with no set-aside designation. Cepheid will provide the agency with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions enable the rapid detection and diagnosis of various infectious diseases, including COVID-19, influenza, respiratory syncytial virus (RSV), and Methicillin-resistant Staphylococcus aureus (MRSA). Cepheid has several Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $1,000,000 Blanket Purchase Agreement with the Indian Health Service and a $1,424,520 Indefinite Delivery Contract with the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 for COVID-19 and respiratory virus testing supplies. These IDVs allow for the continuous procurement of Cepheid's molecular diagnostic products and services by the respective federal agencies.

Generated 4/22/25, 9:42 AM